Showing results (881-890 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|August 20, 2026
A novel conditioning regimen incorporating low-dose cyclophosphamide and thiotepa for haploidentical hematopoietic stem cell transplantation in pediatric patients with severe aplastic anemia at high risk of cardiotoxicityFeng Zhang, Pan Suo, Guan-Hua Hu, et al.
Transplantation and Cellular Therapy|August 19, 2026
Breast cancer risk among survivors of hematopoietic stem cell transplant with or without total body irradiation: A population-based analysisHelena J Janse van Rensburg, Jingxuan He, Ning Liu, et al.
Transplantation and Cellular Therapy|August 19, 2026
High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical TransplantationChristopher C Dvorak, Willem Collier, Soohee Cho, et al.
Transplantation and Cellular Therapy|August 28, 2026
Donor-derived distinct neutrophil subsets in the G-CSF-mobilized peripheral blood grafts predict acute GVHD developmentHuajuan Dai, Chupeng Zhang, Haiyan Zhang, et al.
Transplantation and Cellular Therapy|September 2, 2026
Impact of graft-versus-host disease on relapse and survival in adults with B-cell acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation plus post-transplant cyclophosphamide in resource-limited settingsCesar Homero Gutiérrez-Aguirre, Fernando De la Garza-Salazar, José Carlos Jaime-Pérez, et al.
Transplantation and Cellular Therapy|September 11, 2026
Integrated analysis of hematopoietic changes following heterochronic bone marrow transplantation between young and aged miceJosé Antonio Bejarano-García, Melanie Nufer, Rocío Caracuel, et al.
Transplantation and Cellular Therapy|September 15, 2026
Effect of mesenchymal stem cells on peripheral immune cells in multiple sclerosis: results from an international phase 2 clinical trialIrene Schiavetti, Mark S Freedman, Simon Thebault, et al.
Transplantation and Cellular Therapy|September 6, 2026
Differential impact of GVHD prophylaxis on CMV infection and survival outcomes after cord blood transplantation in the era of letermovirShunto Kawamura, Yu Akahoshi, Hideki Nakasone, et al.
Transplantation and Cellular Therapy|September 26, 2026
Real-World Comparison of Axicabtagene Ciloleucel and Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: A Target Trial EmulationMohammed Zuber, Chia Jie Tan, Joshua Caballero, et al.
Transplantation and Cellular Therapy|October 9, 2026
Impact of Donor Age on Transplant Outcomes in Matched Unrelated Donor Transplantation for MyelofibrosisKazuki Sakatoku, Yutaka Shimazu, Makoto Murata, et al.
Pageof 183